JCRPE (Dec 2019)

Serum Neuron-specific Enolase and S100 Calcium-binding Protein B in Pediatric Diabetic Ketoacidosis

  • Hatem Hamed Elshorbagy,
  • Naglaa Fathy Barseem,
  • Akram Elshafey Elsadek,
  • Ashraf Hamed Al-shokary,
  • Yehia Hamed Abdel Maksoud,
  • Sameh Elsayed Abdulsamea,
  • Iman M. Talaat,
  • Hany Abdelaziz Suliman,
  • Naglaa M. Kamal,
  • Waleed E. Abdelghani,
  • Sanaa Mohammed Azab,
  • Dalia Mohamed Nour El Din

DOI
https://doi.org/10.4274/jcrpe.galenos.2019.2018.0280
Journal volume & issue
Vol. 11, no. 4
pp. 374 – 387

Abstract

Read online

Objective:Neuron-specific enolase (NSE) and S100 calcium-binding protein B (S100B) are markers of different neurological disorders. The aim was to investigate the relationship between NSE and S100B serum concentrations and the severity of diabetic ketoacidosis (DKA) in diabetic children.Methods:Eighty children with DKA, 40 with type 1 diabetes mellitus (T1DM) without DKA and 40 healthy controls were enrolled. Severity of DKA was assessed according to blood pH and bicarbonate concentration. Serum NSE and S100B were measured in all participants. In the DKA group serum NSE and S100B were measured at three time points, at admission and at 12 hours and 24 hours after starting treatment.Results:Children with DKA showed significantly higher serum levels of NSE at all time points compared to children with T1DM without DKA and controls (p0.05). Younger age, lower GCSS, higher glucose and HbA1c, lower pH and lower serum bicarbonate were the risk factors associated with elevated NSE.Conclusion:Serum NSE is elevated in all patients with type 1 DM and, in patients with DKA, correlates with severity of DKA. However, serum S100B concentration did not differ between T1DM with or without DKA and healthy controls.

Keywords